Ebola comes from bats, HIV from primates, and new strains of influenza from birds and pigs. With zoonotic diseases - those capable of transmission from animals to humans - grabbing headlines across the globe, understanding how they work has never been more important.

That's the mission of a new team of researchers led by Dr. Sara Sawyer at the BioFrontiers Institute. By analyzing the genomes of hosts and viruses alike, Sawyer and her team hope to shed some light on why humans are resistant to most animal viruses, and how animal viruses evolve the ability to overcome these obstacles and infect humans.
"These are exactly the kinds of targets that we're after - mammalian genes that determine why viruses infect the species that they do and why they don't infect the species that they don't," said Sawyer.
One example of the work that Sawyer's lab does is a project studying how HIV - the virus that causes AIDS - jumped from primates to humans, and why the virus affects humans differently than some primates.
"Chimpanzees and humans only differ in their genetic code by two percent, yet HIV doesn't make chimpanzees nearly as sick as it makes humans," said Sawyer. "So somewhere in that two percent difference in their genetic code may lie the answer to surviving this devastating disease."
Sawyer's team, which moved to Colorado from the University of Texas at Austin, works primarily with HIV, dengue (the virus that causes dengue fever) and influenza.
They utilize samples from a variety of primate, rodent, bat and other mammalian species in order to understand the genetic reasons why some species are susceptible and others aren't. Genetics may provide the answer to how viruses evolve to infect new species. One of the specialties of this lab is bringing wildlife samples into the lab rather than relying on materials from model organisms (the lab recently received part of a wolf heart in the mail).
The lab, which is housed in the Jennie Smoly Caruthers Biotechnology Building on the CU-Boulder
east campus, operates at biosafety level two, which required a substantial retrofit before Sawyer's team could move in. (The lab does not work with live strains of Ebola, which is highly regulated and requires a biosafety level four lab.)
Sawyer is carving out a niche in the field of virology thanks to her background in evolutionary biology. By applying techniques from evolutionary biology Sawyer hopes to better understand interactions between viruses and their hosts, which could lead to novel methods for preventing future outbreaks. For example, by predicting when and where viruses could transfer to humans, we could implement simple public health measures to protect people - an intriguing prospect given the rapid proliferation of deadly viruses such as Ebola. Read more